519 related articles for article (PubMed ID: 22072065)
1. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score.
Extermann M; Boler I; Reich RR; Lyman GH; Brown RH; DeFelice J; Levine RM; Lubiner ET; Reyes P; Schreiber FJ; Balducci L
Cancer; 2012 Jul; 118(13):3377-86. PubMed ID: 22072065
[TBL] [Abstract][Full Text] [Related]
2. Can older cancer patients tolerate chemotherapy? A prospective pilot study.
Chen H; Cantor A; Meyer J; Beth Corcoran M; Grendys E; Cavanaugh D; Antonek S; Camarata A; Haley W; Balducci L; Extermann M
Cancer; 2003 Feb; 97(4):1107-14. PubMed ID: 12569613
[TBL] [Abstract][Full Text] [Related]
3. Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study.
Extermann M; Reich RR; Sehovic M
Cancer; 2015 Sep; 121(17):2984-92. PubMed ID: 26033177
[TBL] [Abstract][Full Text] [Related]
4. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
5. Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy?
Janssen-Heijnen ML; Extermann M; Boler IE
Crit Rev Oncol Hematol; 2011 Jul; 79(1):43-50. PubMed ID: 20685130
[TBL] [Abstract][Full Text] [Related]
6. MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials.
Extermann M; Bonetti M; Sledge GW; O'Dwyer PJ; Bonomi P; Benson AB
Eur J Cancer; 2004 May; 40(8):1193-8. PubMed ID: 15110883
[TBL] [Abstract][Full Text] [Related]
7. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer.
Soubeyran P; Fonck M; Blanc-Bisson C; Blanc JF; Ceccaldi J; Mertens C; Imbert Y; Cany L; Vogt L; Dauba J; Andriamampionona F; Houédé N; Floquet A; Chomy F; Brouste V; Ravaud A; Bellera C; Rainfray M
J Clin Oncol; 2012 May; 30(15):1829-34. PubMed ID: 22508806
[TBL] [Abstract][Full Text] [Related]
8. Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents.
Pond GR; Siu LL; Moore M; Oza A; Hirte HW; Winquist E; Goss G; Hudes G; Townsley CA
J Clin Oncol; 2008 Mar; 26(8):1324-30. PubMed ID: 18323557
[TBL] [Abstract][Full Text] [Related]
9. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
11. The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders.
Polizzotto MN; Tam CS; Milner A; Januszewicz EH; Prince HM; Westerman D; Wolf MM; Seymour JF
Cancer; 2006 Aug; 107(4):773-80. PubMed ID: 16847886
[TBL] [Abstract][Full Text] [Related]
12. A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
Valcárcel D; Montesinos P; Sánchez-Ortega I; Brunet S; Esteve J; Martínez-Cuadrón D; Ribera JM; Tormo M; Bueno J; Duarte R; Llorente A; Torres JP; Guardia R; Sanz MA; Sierra AJ;
Cancer; 2012 Jan; 118(2):410-7. PubMed ID: 21717435
[TBL] [Abstract][Full Text] [Related]
13. Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients.
Marinello R; Marenco D; Roglia D; Stasi MF; Ferrando A; Ceccarelli M; Bertetto O; Molaschi M; Ciccone G
Arch Gerontol Geriatr; 2009; 48(2):222-6. PubMed ID: 18336933
[TBL] [Abstract][Full Text] [Related]
14. Predicting chemotherapy toxicity in older adults with lung cancer.
Nie X; Liu D; Li Q; Bai C
J Geriatr Oncol; 2013 Oct; 4(4):334-9. PubMed ID: 24472476
[TBL] [Abstract][Full Text] [Related]
15. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Hurria A; Zuckerman E; Panageas KS; Fornier M; D'Andrea G; Dang C; Moasser M; Robson M; Seidman A; Currie V; VanPoznak C; Theodoulou M; Lachs MS; Hudis C
J Am Geriatr Soc; 2006 Jul; 54(7):1119-24. PubMed ID: 16866685
[TBL] [Abstract][Full Text] [Related]
16. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
[TBL] [Abstract][Full Text] [Related]
17. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Zauderer M; Howard J; Hudis C
Breast Cancer Res Treat; 2005 Jul; 92(2):151-6. PubMed ID: 15986124
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of current practice: management of chemotherapy-related toxicities.
Lheureux S; Clarisse B; Launay-Vacher V; Gunzer K; Delcambre-Lair C; Bouhier-Leporrier K; Kaluzinski L; Maron D; Ngo MD; Grossi S; Dubois B; Zalcman G; Joly F
Anticancer Drugs; 2011 Oct; 22(9):919-25. PubMed ID: 21795972
[TBL] [Abstract][Full Text] [Related]
19. Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial.
Brain EG; Mertens C; Girre V; Rousseau F; Blot E; Abadie S; Uwer L; Bourbouloux E; Van Praagh-Doreau I; Mourey L; Kirscher S; Laguerre B; Fourme E; Luneau S; Genève J; Debled M
Crit Rev Oncol Hematol; 2011 Oct; 80(1):160-70. PubMed ID: 21035352
[TBL] [Abstract][Full Text] [Related]
20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
